Short-term rituximab and methylprednisolone therapy led to restoration of TNFR1 density level on TNFR1+TNFR2+double-positive T cells in rheumatoid arthritis reflecting the effectiveness of treatment
Research output: Contribution to journal › Meeting Abstract › peer-review
